Abstract |
|
Authors | Xiaomeng Xie, Xueyin Zu, Feifei Liu, Ting Wang, Xiangyu Wang, Hanyong Chen, Kangdong Liu, Penglei Wang, Fangfang Liu, Yan Zheng, Ann M Bode, Zigang Dong, Dong Joon Kim |
Journal | Molecular carcinogenesis
(Mol Carcinog)
Vol. 58
Issue 7
Pg. 1248-1259
(07 2019)
ISSN: 1098-2744 [Electronic] United States |
PMID | 31100197
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2019 Wiley Periodicals, Inc. |
Chemical References |
- Antineoplastic Agents
- Benzocycloheptenes
- CCNA2 protein, human
- CCNB1 protein, human
- Cyclin A2
- Cyclin B1
- Plant Preparations
- Protein Kinase Inhibitors
- Poly(ADP-ribose) Polymerases
- MAP2K2 protein, human
- MAP Kinase Kinase 1
- MAP Kinase Kinase 2
- MAP2K1 protein, human
- purpurogallin
|
Topics |
- Animals
- Antineoplastic Agents
(pharmacology)
- Apoptosis
(drug effects)
- Benzocycloheptenes
(pharmacology)
- Cell Line, Tumor
- Cyclin A2
(biosynthesis)
- Cyclin B1
(biosynthesis)
- Esophageal Neoplasms
(drug therapy, pathology)
- Esophageal Squamous Cell Carcinoma
(drug therapy, pathology)
- Female
- G2 Phase Cell Cycle Checkpoints
(drug effects)
- Humans
- MAP Kinase Kinase 1
(antagonists & inhibitors)
- MAP Kinase Kinase 2
(antagonists & inhibitors)
- Mice
- Plant Preparations
(pharmacology)
- Poly(ADP-ribose) Polymerases
(metabolism)
- Protein Kinase Inhibitors
(pharmacology)
- S Phase Cell Cycle Checkpoints
(drug effects)
- Signal Transduction
(drug effects)
- Xenograft Model Antitumor Assays
|